Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other ...

Mads Krogsgaard Thomsen, CEO of Novo Nordisk Foundation, discusses European competitiveness.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

European shares held steady with slight gains in financials and healthcare despite global uncertainties over U.S. President Donald Trump's proposed tariffs. The market's cautious optimism was ...

(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses ...

En 52-årig fodboldfar er blevet idømt 20 dages betinget fængsel i en sag om vold mod en 77-årig fodbolddommer. Det oplyser ...

Ifølge USA's præsident, Donald Trump, er softwarefirmaet Microsoft i forhandlinger om at købe en del af det sociale medie ...

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

By Nikhil Sharma and Pranav Kashyap (Reuters) -European shares rose on Tuesday, buoyed by gains in the healthcare and luxury ...

Mexico and China — as he has increasingly spoken of the U.S. taking Greenland off Denmark’s hands. Danish multinational pharmaceutical giant Novo Nordisk is the sole owner of semaglutide ...

Jan 17 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said ... as markets await clarity on tariffs by Trump on Canada, Mexico 1:52 AM UTC · Updated ago Technologycategory Microsoft, Meta ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?